MICHAEL W ROGERS
CIK 1244159 · See Remarks · last filed 2025-06-11
MICHAEL W ROGERS is a corporate insider who has filed 55 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for AKBA, was dated Jun 11, 2025. Across all open-market trades the lifetime net is −$405.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.70M
10
55
-$405.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKBA | Director | 161,729 | $0.92 | $149.5K | $0 | 8 | 2025-06-11 |
| Aravive, Inc. (ARAV) Delisted | Director | — | $0.04 | — | $0 | 3 | 2022-09-26 |
| EYPT | Director | 119,167 | $13.03 | $1.55M | $0 | 5 | 2019-06-27 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | See Remarks | — | $33.00 | — | $0 | 2 | 2019-05-16 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Director | 0 | — | — | $0 | 4 | 2018-12-13 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 11 | 2017-12-19 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Chief Financial Officer | 40,713 | $0.66 | $26.9K | -$405.9K | 10 | 2016-05-13 |
| Fortress Biotech, Inc. (CNDO) Delisted | Director | — | — | — | $0 | 2 | 2013-02-11 |
| BG Medicine, Inc. (BGMD) Delisted | EVP, CFO and Treasurer | — | — | — | $0 | 2 | 2012-02-24 |
| IDEV | Executive Vice President | 0 | $90.39 | $0 | $0 | 6 | 2009-02-25 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-11 | AKBA | Grant (A) | +35,700 | $0 | EDGAR |
| 2024-06-10 | AKBA | Grant (A) | +30,000 | $0 | EDGAR |
| 2023-06-08 | AKBA | Grant (A) | +30,000 | $0 | EDGAR |
| 2022-09-26 | Aravive, Inc. (ARAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | AKBA | Grant (A) | +13,700 | $0 | EDGAR |
| 2021-09-13 | Aravive, Inc. (ARAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | AKBA | Grant (A) | +13,700 | $0 | EDGAR |
| 2020-09-17 | Aravive, Inc. (ARAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-09 | AKBA | Grant (A) | +13,700 | $0 | EDGAR |
| 2019-06-27 | EYPT | Grant (A) | — | $0 | EDGAR |